Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management.

Orgiano L
;Pani F;Pusceddu V;Madeddu C;Massa E;CUBEDDU, ALESSIO;Demurtas L;PUSOLE, GRAZIA;Puzzoni M;Boi F;Mariotti S;Scartozzi M.
2016-01-01
2016
Inglese
JOURNAL OF CLINICAL ONCOLOGY
34
15004
56
56
1
Comitato scientifico
internazionale
scientifica
regorafenib
no
266
1 Contributo su Rivista::1.5 Abstract in rivista
info:eu-repo/semantics/article
1.5 Abstract in rivista
none
Orgiano, L; Pani, F; Pusceddu, V; Astara, G; Madeddu, C; Massa, E; Cubeddu, Alessio; Demurtas, L; Dessì, A; Lai, E; Mascia, R; Tolu, S; Pusole, Grazia; Puzzoni, M; Boi, F; Mariotti, S; Scartozzi, M.
17
Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie